In honor of Breast Cancer Awareness Month, Pevonia is delighted to announce that it will donate 5% of all October profits of Pevonia’s bestselling and award-winning RS2 Rosacea Skincare Line and the NEW on-trend Power Repair® Rapid-Restore Neck & Chest Serum and Cream to the National Breast Cancer Foundation.

Think Pink with the RS2 Line that is uniquely formulated to provide your clients’ skin with vaso-constricting and repairing benefits as well as UV protection. Ideal for clients with hypersensitivity, redness, and Rosacea the RS2 Line diffuses blotchiness and redness while hydrating the skin, leaving behind a clear complexion.

Pevonia’s NEW Power Repair Rapid-Restore Neck & Chest Serum and Cream is a perfect regimen addition for those seeking to repair sun damage and all seeking tighter, smoother, skin around their neck, bust/chest for a healthier, more youthful, appearance. This unique 2-in-1 product helps to boost elasticity, tone, hydrate and nourish the neck & décolleté and is recommended for all skin types.

Pevonia is proud to offer support to this wonderful organization while providing help and inspiring hope to those affected by breast cancer. Pevonia welcomes all of our Spa Partners to join us in promoting this initiative and doing what they can to help empower women and men have the best chance of living full and healthy lives.


About Pevonia
Pevonia believes the most powerful ingredients in skincare come from the safest source – nature. For nearly three decades, Pevonia has used highly sustainable processes in line with the company’s stance on environmental conservation, and in 2019, the company became a proud supporter of charity: water. Pevonia delivers outstanding multicultural solutions to nearly 130 countries by restoring, de-aging and revitalizing our largest and most visible organ…our skin! The company tests only on humans and is a renowned leader in delivering natural skincare solutions to elite spas and leading aestheticians globally. As a multi-award winning brand, Pevonia is coveted by celebrities and beauty/wellness influencers and often featured in leading worldwide press, praising our natural solutions for delivering outstanding, instant and long-term results.

800-351-3516  www.pevoniapro.com

Jim McKenney joined BioPhotas in August of 2019 to manage the company’s dramatic international growth and develop new global markets for the award winning Celluma SERIES of LED devices. Jim brings more than 20 years of leadership experience in business development and sales management. He has worked with some of the world’s largest and most successful healthcare companies and has a proven track record with start-ups. In addition to his experience in contract manufacturing and healthcare, he has successfully started and exited two real estate investment firms.  Jim has the ability to develop strong relationships while driving sustainable growth through a process and analytics driven approach. Jim met his wife Sheryl at the University of Arizona. They are raising three teenage sons and currently reside in Southern California.

 

The two organizations will compare care methods for treating patients with eczema

 

LOS ANGELES, October 1, 2019 — Science 37, the industry leader in virtual clinical trials, and the Keck School of Medicine of the University of Southern California (USC) recently announced a partnership agreement that will support the execution of a $3.4 million study funded by the National Institutes of Health (NIH)—the largest telemedicine-based dermatology study ever funded by the organization. The new collaboration combines the expertise from Science 37 in executing virtual clinical studies with the extensive research capabilities of the Keck School to determine whether telemedicine can deliver care that is equivalent to being seen in-person for patients with eczema.

 

“Our experts are committed to exploring innovative ways to provide advanced care for our patients,” says David Peng, MD, MPH, chair and professor of clinical dermatology at the Keck School. “This includes examining how technology-enabled healthcare delivery can be used to allow patients to more easily access the care they need.”

 

The study, led by April Armstrong, MD, MPH, associate dean of clinical research and professor of dermatology at the Keck School, and supported by the NIH grant, will evaluate telemedicine as a method of care for more than 300 patients with atopic dermatitis, a form of eczema. Many patients with eczema or other chronic skin conditions experience poor health outcomes because they lack regular access to dermatologists. In this study, Armstrong and her research team will determine whether telemedicine can improve access, reduce disease severity, improve quality of life, and save healthcare costs.

 

“A research partnership with the Keck School of Medicine of USC underscores the bright future ahead for telemedicine, virtual studies, and patient-centered research,” says Jonathan Cotliar, MD, chief medical officer at Science 37. “The road to improved health outcomes begins with delivering care at the patient’s convenience whenever possible, and we’re excited to embark on research with USC that could transform the patient experience for those with eczema.”

 

Researchers will use NORA® from Science 37, the industry’s first and only comprehensive tool to fully operationalize a virtual study, to communicate with patients during the study. Patients will also submit ePROs (electronic patient-reported outcomes) through NORA. The platform is purpose-built to support the unique workflows, processes, and systems of virtual studies and adheres to the highest industry quality and regulatory standards. It digitally centralizes data collection and is integrated into a sponsor’s system to ensure the automated exchange of reliable and high-quality data available in near-real time. NORA also supports patient centricity by accelerating recruitment and providing a direct, personalized patient experience for those who participate in research.

 

About Science 37

Enabled by digital technologies and innovation, Science 37® is reimagining clinical research. The patient experience is transformed by pushing research beyond the confines of offices and hospitals and into the comfort and convenience of the home. Recognized as the industry leader, our unrivaled expertise and comprehensive platform, along with direct, concierge-level patient services gives partners confidence that Science 37 will execute a study with the highest regard for patient safety and data integrity. The Science 37 model is flexible, meeting companies at any point along the virtual study journey. Learn more at Science 37, and follow Science 37 on Twitter, LinkedIn, and Facebook.

 

This research was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health (grant R01AR073486).

This past summer, Ian Bell, senior project manager for global spa consultancy and think tank, Raison d’Etre, was invited by Mònica Alatorre, dean of hospitality and tourism at UDLA in Quito, Ecuador, to give a presentation to 31 fourth year students currently visiting Puerto Ayora, Galapagos.

 

Bell focused the lecture on the global wellness industry, the current global wellness trends, and, more specifically, the current wellness offering in Ecuador and the opportunities for Ecuador to grow into a wellness destination.

 

The students were visiting the Galapagos Islands as part of their fourth semester in order to understand the different tourist destinations Ecuador has to offer. Bell was in the Galapagos Islands working with leading tour operator in the Galapagos Islands and Ecuador, Metropolitan Touring, in developing their wellness concept and also to open their new spa at Finch Bay – one of National Geographic’s Unique Lodges of The World.

 

Speaking from the Galapagos Islands, Bell said, “Ecuadorians take great pride in the extraordinary beauty of their country, especially the Galapagos Islands. Metropolitan Touring considers themselves stewards of the land and works tirelessly to preserve the amazing biodiversity of this pristine haven to the benefit of its inhabitants, visitors, and abundant wildlife. This presents an opportunity to develop a new standard of spa and wellness concepts in Ecuador, by applying the sample principles and passion to the well-being of people. At Raison d’Etre, we are very much looking forward to working with Metropolitan Touring in achieving this as, together, we continue to develop their wellness standards, starting with their spa here at Finch Bay.”

Global spa consultancy Raison d’Etre has been awarded the distinguished title of Best Wellness Concept and Brand Creator for Scandinavia in the LUX 2019 Hotel and Spa Awards. The Awards by LUX Life Magazine looks to honor candidates who stand out from the competition and work tirelessly to provide their guests with seamless and tranquil wellness experiences.

 

The award win honors the Stockholm, Sweden-based consultancy’s expertise in creating award winning spas, spa brands, and spa concepts worldwide, including their very own brand LivNordic. Today, Raison d’Etre has worked on over 120 spas in 60 countries, winning more than 50 awards for ground-breaking innovations and revolutionary facilities that champion design, wellness, nutrition, and beauty.

 

To ensure that only the best and brightest walked away with one of its prestigious accolades, judges conducted a rigorous 12-month investigation into each candidate. Nominees were analyzed within their respective regions of operation and rated on employee skills, services on offer, customer feedback, and their wider market reputation. Judges also reviewed supporting evidence (submitted by the nominees) before making the ultimate decision.

 

Receiving the award, Raison d’Etre’s managing director, Anna-Cari Gund, says, “Our mission is to create truly unique spaces. We are extremely proud to have risen to the challenge of creating this and to see such a positive response from guests.”

Royal Philips released the findings of its fifth annual Philips Global Beauty Index, surveying over 12,000 women from 12 different countries. The extensive international study explores the attitudes and perceptions of women from around the globe to uncover how they define beauty, the role it plays in their lives, and how the industry is supporting them.

 

 This year, Philips gazed into the future, examining the evolution of beauty routines globally and the important role that technology and personalization are set to play. The findings reveal the developments women are most excited to see, in addition to how perceptions of beauty are being redefined. It further shows how technology is helping women to make more informed choices about products, influencing where, how, and when women are getting their beauty knowledge.

 

 “This year marks our fifth annual Global Beauty Index, which is very exciting. Having five years of results to compare allows us to make some truly meaningful comparisons between past and present beauty trends, as well as make informed predictions about how the world of beauty is likely to evolve,” said Bianca Heiszwolf, business leader beauty at Philips. “These results are incredibly important to Philips and help us to realize our vision to empower women and provide them with efficient, advanced beauty solutions that respond to their personal needs.”

 

 Women are most excited about receiving personalized beauty advice. This year’s index reveals that when it comes to future beauty technology, women are most excited about personalized advice on how to keep their hair and skin healthy (65%). Women in China and India are particularly eager for future developments in both these areas (85% and 81% respectively). Mobile apps are likely to play a particularly important role in women’s beauty routines, with over half of women surveyed (58%) welcoming an app that scans the skin to identify moisture, pores, lines, and wrinkles over time. Similarly, 57% of respondents would welcome a service or platform that takes hair type, hair structure, hair goals, and other preferences into consideration, applying the information to create an ideal ingredient combination.

 

 Emotional balance and positive mindset are closely linked to feeling beautiful. The 2019 Index shows that 60% of women globally consider themselves to be beautiful. While this is lower than in 2018 (65%), this year’s figure is still 13 points higher than the first Index in 2015 (47%), showing a positive trend over time. This may be attributed to the more holistic approach that women are now taking to beauty, with a large majority of women surveyed believing that having a positive mindset (88%) and feeling emotionally balanced (84%) are the most important aspects of feeling beautiful.

 

 Additionally, more than six in 10 women around the world are already taking a holistic approach to beauty, while 44% of women worldwide say they expect to see a more holistic approach, which connects health and beauty spread across the industry in the next five years.

 

 Women now seek beauty knowledge from a range of sources. With the evolution of technology, there are now more places than ever to find beauty inspiration and knowledge. While many women are looking to online communities for advice, the 2019 Philips Global Beauty Index reveals that it is actually people closer to home whom women depend on most for information. Surprisingly, 49% of women still turn to their friends, family, or colleagues for beauty advice and this figure grows to 63% in Korea and 60% in Turkey. This is notably higher than the number of women who turn to social media, which is 37% globally, in comparison.

 

 That said, one in four women globally (25%) now turn to bloggers or vloggers to discover new beauty brands or products – a far higher figure than those turning to traditional celebrities (15% globally), showing just how much influence these social-media-savvy individuals have garnered over a relatively short period of time.

 

 In summary, while there is a continued trend of women finding information from a range of sources, and who are welcoming to different technologies, the most important development is that women seek personalized solutions that will help them to identify and solve their individual health and beauty concerns.

Color Up is officially oncology-approved by Oncology Spa Solutions. All products were tested in three hospitals on oncology patients and by therapists (aestheticians and massage therapists) using them on patients. 

 

Color Up COO and co-owner Shauna Blanch says, “We started on this journey to help people find mental, physical and emotional healing, wellness, and balance through the cannabis plant. After many years of hard work, we are able to do that in the most powerful way. Not only are all of our ingredients safe, but cannabis has long been known to combat not only internal cancers but also skin cancer. Adding CBD to our already effective formulations adds another level of healing for those with cancer.

 

Through speaking with many patients, and a few oncologists, we have learned that oncology patients are scared to use anything that doesn’t specify that it’s oncology safe because there are so many ingredients that can upset and cause a reaction on their very sensitive skin. Now, they can confidently Color Up their care with our carefully formulated products. 

 

Furthermore, many patients experience internal, emotional turmoil due to not feeling presentable or pretty before, during, and after treatment. They are scared to do things that make them feel good in fear of coming into contact with something that will make them weak or ill. Now, they can go to any aesthetician or massage therapist who utilizes Color Up and safely receive a treatment.”

 

The Color Up Cares initiative intends to bring healing and balance into the lives of those fighting cancer by raising funds for research, meals, wigs, and other ancillary items, as well as providing free spa treatment days and oncology safe self-care products. 

 

  1. Started Oct. 1, Color Up began donating 5% of all in-store sales generated by the Color Up Wellness Center in Denver to a different cancer organization each quarter. This quarter, they will donate the percentage of sales from Oct., Nov., and Dec. to The Breast Cancer Research Fund.
  2. Color Up Cares Day will be hosted once per quarter where the team will provide free CBD facials to people who are currently fighting, or who are survivors of cancer. The first one will be November 23rd from 10 a.m.-6 p.m. Each person will receive a facial and a take-home self-care kit of products from Color Up. The therapists are all donating their time for these days. 

The dangers of ultraviolet radiation exposure, which most often comes from the sun, are well-known. At The Physiological Society’s Extreme Environmental Physiology conference, recently, W. Larry Kenney of Penn State University discussed how broad its effects can be, from premature aging to cancer, and how this can be influenced by different skin tones and the use of sunscreen.

 

Athletes ranging from hikers to tennis players to runners exceed the recommended ultraviolet exposure limit by up to eight-fold during the summer and autumn months. While regular physical activity is associated with a reduced risk of most cancers, skin cancer is an exception. For malignant skin cancer, those in the 90th percentile for physical activity have an increased risk of cancer than those in the 10th percentile. Sun protection in these groups is especially important, as multiple studies demonstrate an elevated risk of skin cancer for those who regularly participate in outdoor sports or exercise.

 

The ultraviolet radiation spectrum is categorized by wavelength as UVA (320 to 400 nanometers), UVB (290 to 320 nanometers), and UVC (200 to 290 nanometers) and the biological effects vary per type. UVA constitutes around 95% of ultraviolet radiation that reaches the earth’s surface, with the remainder being UVB. In the skin, UVA is able to reach the skin’s blood circulation, but most of UVB is absorbed in the outer layers of the skin, called the epidermis and upper dermis, due to its shorter wavelengths.

 

Skin pigmentation is another factor that affects the skin’s response to sun exposure. Ultraviolet radiation affects the body’s ability to create two important substances, vitamin D and folate, which contribute to both a healthy pregnancy and early childhood development. It helps vitamin D be synthesized, whereas it causes folate to break down.

 

There is a theory that suggests that early human populations, living in equatorial Africa, evolved skin pigmentation to protect themselves from folate degradation. This theory also says that depigmentation then occurred as humans moved away from the equator to allow for higher levels of vitamin D synthesis.

 

Commenting on his talk, Professor Kenney said, “Sun protection in athletes is especially important, as multiple studies demonstrate an elevated risk of skin cancer for those who regularly participate in outdoor sports or exercise. Surprisingly, fewer than 25% of surveyed athletes reported regular use of sunscreen, so there is clearly more awareness-raising that needs to be done.”

CIDESCO International, the world’s major international beauty therapy association, presented Lydia Sarfati, CEO and Founder of Repêchage® with the Médaille du Mérite Award at the CIDESCO World Congress’s Architecture of Beauty Gala Dinner, held at the Willis Tower, on September 21, 2019.

Sarfati, who serves as Chairman of CIDESCO Section U.S.A., was nominated and voted for by other CIDESCO Sections, with the decision ratified by the Board of Directors of CIDESCO.

This prestigious award, which has been distributed to members since 1960, is in recognition of Sarfati’s ongoing and tireless efforts to elevate professional standards and status in esthetics education and the beauty industry. In 2018, Sarfati was instrumental in bringing the CIDESCO certificate program to the United States after many years of working with individual schools and state boards. Every other year, CIDESCO honors members who have contributed with dedication and commitment to the industry.

“It is a great honor to be recognized by CIDESCO, an organization I am so proud to be part of for the last 15 years,” said Sarfati. “I look forward to continuing to represent and work with CIDESCO to elevate the field of esthetics and the beauty industry. I am excited for the new developments that CIDESCO will bring to esthetics industry in the U.S. and abroad.”

For more about Repêchage and Lydia Sarfati: www.repechage.com
To learn more about CIDESCO visit www.cidesco.com

About Repêchage: Since 1980, Repêchage® has created a full range of seaweed-based skincare products featured at top spas and salons globally. Forerunners in sea plant technologies and pioneers in seaweed treatments and cosmetics in the US, Repêchage® researchers seek out specific seaweeds beneficial for a range of skin care concerns. Repêchage seaweed is sustainably harvested from the coast of Maine, USA and France, and then processed with a proprietary extraction method at the ISO 9001:2015 certified Repêchage® manufacturing facility, located at the Repêchage® Headquarters in Secaucus, NJ, USA. Through this proprietary extraction process, Repêchage seaweeds retain 12 vitamins, 18 amino acids, 42 trace elements and minerals, and phlorotannins – the only elements your skin needs for deep surface hydration and balance.
18002487546  www.repechage.com

Cassiopea SpA, a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action to address long-standing and essential dermatological conditions, announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) seeking marketing approval for clascoterone cream 1% for the treatment of acne.

 

 

Clascoterone cream 1% is under investigation as a first-in-class, topical androgen receptor inhibitor for the treatment of acne. Clascoterone is a topically delivered small molecule that penetrates the skin to reach the androgen receptors of the sebaceous gland. It aims to be the first effective and safe topical androgen inhibitor therapy that does not have systemic side effects.

 

 

Clascoterone cream 1% targets androgen receptors at the site of application, inhibiting the local (skin) effects of dihydrotestosterone, a key driver of acne lesion development. Laboratory studies show that clascoterone inhibits lipid production from oil producing cells (sebocytes) and reduces proinflammatory cytokines, mediators influenced by androgens. Thus, pathways that foster acne lesion development are disrupted by clascoterone. Unlike oral hormonal therapies for acne, it may be used in both male and female patients.

 

 

“This is noteworthy because it’s been so long since there has been a new, first-in-class molecule for the treatment of acne, particularly given that it is a topical treatment that targets the androgen receptor and works on sebocytes to mediate lipid production and inflammation,” said Dr. Lawrence Eichenfield, chief of pediatric and adolescent dermatology at Rady Children’s Hospital in San Diego, California. “Giving physicians another treatment option for their patients who struggle with acne is tremendously important.”

 

 

Last year, Cassiopea announced topline results from two pivotal phase three clinical trials for clascoterone cream 1% demonstrating highly statistically significant improvements for all primary clinical endpoints. No treatment-related serious adverse events among patients have been recorded during the trials; local skin reactions, if present, were similar to vehicle and predominantly classified as mild. Safety results, announced earlier this year, were confirmed in an open-label safety study for a treatment period of up to one year, with an expanded drug application surface area that included both the face and trunk. The extended duration and coverage of the topically applied drug did not increase the incidence of significant side effects.

 

 

“If approved, clascoterone cream 1% will be the first new mechanism of action in the treatment of acne in nearly 40 years, offering dermatologists and patients a new and effective therapeutic alternative,” said Diana Harbort, CEO of Cassiopea. “We’re focused on the urgency to treat skin conditions that can leave not only physical scars, but also emotional scars. That’s why innovation is so critical. We are committed to finding a way to treat acne that addresses the root causes of the condition.”

Page 1 of 86

Featured Company

  • Dr. Jeff Skin Care / Beauty AtticaDr. Jeff Skin Care / Beauty AtticaDescription: About Dr. Jeff Skin Care/Beauty Attica, Inc. Beauty Attica, incorporated in Redmond, Washington in 1996, was relocated to the metro Los Angeles area in June 1999. It is the marketing arm of Dr. Jeff Professional Skin Care products domesticall ...

Inside Aesthetics

Next-Level Learning

  • Christine Valmy International School of Esthetics & CosmetologyChristine Valmy International School of...Description: Christine Valmy International School of Esthetics & Cosmetology offers a quality education in the beauty industry, based on the teachings of the Founder of Esthetics in the United States—Ms. Christine Valmy. Ms. Valmy opened her very first school ...